TheHerdLocker.com Skip to content…
  • Recent
  • Popular
The most popular thoughts. Popular rankings for #oncology show you the articles which have had the most shares over the past 7 days, 30 days or the past 6-7 months.

We show you the original tweet, and the 'share' number is the number of times that the content was linked to by other twitter users: as retweets, duplicate posts, shortened URLs and so on.

Remember to check out the recent reports, showing the latest filtered tweets as fast as we can process them.

7 days 30 days 6 months+

Busy? Get Free Weekly Reports

    Previous1..3456789..18Next
First Shared by Shares URL Content Date
@OncoPublisher 0 https://medicalxpress.com/news/2020-06-global-burden-thyroid-cancer.html Global burden of thyroid cancer is increasing #Oncology #MedTwitter https://medicalxpress.com/news/2020-06-global-burden-thyroid-cancer.html 30-Jun-20 23:08 Open Tweet
@OncoPublisher 0 https://www.healio.com/news/hematology-oncology/20200630/black-patients-less-likely-to-undergo-surgery-for-esophageal-cancer Black patients less likely to undergo surgery for esophageal cancer #Oncology #MedTwitter https://www.healio.com/news/hematology-oncology/20200630/black-patients-less-likely-to-undergo-surgery-for-esophageal-cancer 30-Jun-20 23:20 Open Tweet
@OncoPublisher 0 https://www.empr.com/home/news/pembrolizumab-keytruda-new-approval-unresectable-metastatic-microsatellite-instability-high/ Keytruda Approved as First-Line Treatment of MSI-H or dMMR Colorectal Cancer #Oncology #MedTwitter https://www.empr.com/home/news/pembrolizumab-keytruda-new-approval-unresectable-metastatic-microsatellite-instability-high/ 30-Jun-20 23:27 Open Tweet
@OncoPublisher 0 https://www.empr.com/home/news/phesgo-pertuzumab-trastuzumab-hyaluronidase-metastatic-her2-breast-cancer/ Phesgo Approval Allows for Faster Administration of Pertuzumab and Trastuzumab #Oncology #MedTwitter https://www.empr.com/home/news/phesgo-pertuzumab-trastuzumab-hyaluronidase-metastatic-her2-breast-cancer/ 30-Jun-20 23:33 Open Tweet
@OncoPublisher 0 https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/covid-19-coronavirus-active-anticancer-treatment-poor-prognosis/ Active Anticancer Treatment Associated With Poor COVID-19 Prognosis - Cancer Therapy Advisor #Oncology #MedTwitter https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/covid-19-coronavirus-active-anticancer-treatment-poor-prognosis/ 01-Jul-20 02:11 Open Tweet
@OncoPublisher 0 https://medcitynews.com/2020/06/merck-cancer-immunotherapy-drug-gets-expansion-to-biomarker-based-labeling/ Merck cancer immunotherapy drug gets expansion to biomarker-based labeling - MedCity News #Oncology #MedTwitter https://medcitynews.com/2020/06/merck-cancer-immunotherapy-drug-gets-expansion-to-biomarker-based-labeling/ 01-Jul-20 02:16 Open Tweet
@OncoPublisher 0 https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/breast-cancer-polygenic-risk-score-tool-predicts-latina-women/ Polygenic Risk Score Tool Predicts Breast Cancer Risk in Latina Women - Cancer Therapy Advisor #Oncology #MedTwitter https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/breast-cancer-polygenic-risk-score-tool-predicts-latina-women/ 01-Jul-20 02:21 Open Tweet
@OncoPublisher 0 https://www.news-medical.net/news/20200630/Glowing-dye-may-illuminate-tumors-during-surgery.aspx Glowing dye may illuminate tumors during surgery #Oncology #MedTwitter https://www.news-medical.net/news/20200630/Glowing-dye-may-illuminate-tumors-during-surgery.aspx 01-Jul-20 02:21 Open Tweet
@diagnostic_mdpi 0 https://www.mdpi.com/2075-4418/10/7/443 #mdpidiagnostics Clinical Perspective and Translational #Oncology of #LiquidBiopsy @usal 🙌https://www.mdpi.com/2075-4418/10/7/443 https://t.co/vPHEzmNCea 01-Jul-20 02:33 Open Tweet
@pharma_jonpi 0 https://www.consalud.es/ecsalud/internacional/boehringer-ingelheim-amplia-cartera-inmuno-oncologia_81992_102.html Boehringer Ingelheim Amplía su Cartera en Inmuno-Oncología con la Adquisición de Northern Biologics . #oncology https://www.consalud.es/ecsalud/internacional/boehringer-ingelheim-amplia-cartera-inmuno-oncologia_81992_102.html 01-Jul-20 05:05 Open Tweet
  • @OncoPublisher
    30-Jun-20 23:08 Open Tweet
    0 shares
    • https://medicalxpress.com/news/2020-06-global-burden-thyroid-cancer.html
    • Global burden of thyroid cancer is increasing #Oncology #MedTwitter https://medicalxpress.com/news/2020-06-global-burden-thyroid-cancer.html
  • @OncoPublisher
    30-Jun-20 23:20 Open Tweet
    0 shares
    • https://www.healio.com/news/hematology-oncology/20200630/black-patients-less-likely-to-undergo-surgery-for-esophageal-cancer
    • Black patients less likely to undergo surgery for esophageal cancer #Oncology #MedTwitter https://www.healio.com/news/hematology-oncology/20200630/black-patients-less-likely-to-undergo-surgery-for-esophageal-cancer
  • @OncoPublisher
    30-Jun-20 23:27 Open Tweet
    0 shares
    • https://www.empr.com/home/news/pembrolizumab-keytruda-new-approval-unresectable-metastatic-microsatellite-instability-high/
    • Keytruda Approved as First-Line Treatment of MSI-H or dMMR Colorectal Cancer #Oncology #MedTwitter https://www.empr.com/home/news/pembrolizumab-keytruda-new-approval-unresectable-metastatic-microsatellite-instability-high/
  • @OncoPublisher
    30-Jun-20 23:33 Open Tweet
    0 shares
    • https://www.empr.com/home/news/phesgo-pertuzumab-trastuzumab-hyaluronidase-metastatic-her2-breast-cancer/
    • Phesgo Approval Allows for Faster Administration of Pertuzumab and Trastuzumab #Oncology #MedTwitter https://www.empr.com/home/news/phesgo-pertuzumab-trastuzumab-hyaluronidase-metastatic-her2-breast-cancer/
  • @OncoPublisher
    01-Jul-20 02:11 Open Tweet
    0 shares
    • https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/covid-19-coronavirus-active-anticancer-treatment-poor-prognosis/
    • Active Anticancer Treatment Associated With Poor COVID-19 Prognosis - Cancer Therapy Advisor #Oncology #MedTwitter https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/covid-19-coronavirus-active-anticancer-treatment-poor-prognosis/
  • @OncoPublisher
    01-Jul-20 02:16 Open Tweet
    0 shares
    • https://medcitynews.com/2020/06/merck-cancer-immunotherapy-drug-gets-expansion-to-biomarker-based-labeling/
    • Merck cancer immunotherapy drug gets expansion to biomarker-based labeling - MedCity News #Oncology #MedTwitter https://medcitynews.com/2020/06/merck-cancer-immunotherapy-drug-gets-expansion-to-biomarker-based-labeling/
  • @OncoPublisher
    01-Jul-20 02:21 Open Tweet
    0 shares
    • https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/breast-cancer-polygenic-risk-score-tool-predicts-latina-women/
    • Polygenic Risk Score Tool Predicts Breast Cancer Risk in Latina Women - Cancer Therapy Advisor #Oncology #MedTwitter https://www.cancertherapyadvisor.com/home/cancer-topics/breast-cancer/breast-cancer-polygenic-risk-score-tool-predicts-latina-women/
  • @OncoPublisher
    01-Jul-20 02:21 Open Tweet
    0 shares
    • https://www.news-medical.net/news/20200630/Glowing-dye-may-illuminate-tumors-during-surgery.aspx
    • Glowing dye may illuminate tumors during surgery #Oncology #MedTwitter https://www.news-medical.net/news/20200630/Glowing-dye-may-illuminate-tumors-during-surgery.aspx
  • @diagnostic_mdpi
    01-Jul-20 02:33 Open Tweet
    0 shares
    • https://www.mdpi.com/2075-4418/10/7/443
    • #mdpidiagnostics Clinical Perspective and Translational #Oncology of #LiquidBiopsy @usal 🙌https://www.mdpi.com/2075-4418/10/7/443 https://t.co/vPHEzmNCea
  • @pharma_jonpi
    01-Jul-20 05:05 Open Tweet
    0 shares
    • https://www.consalud.es/ecsalud/internacional/boehringer-ingelheim-amplia-cartera-inmuno-oncologia_81992_102.html
    • Boehringer Ingelheim Amplía su Cartera en Inmuno-Oncología con la Adquisición de Northern Biologics . #oncology https://www.consalud.es/ecsalud/internacional/boehringer-ingelheim-amplia-cartera-inmuno-oncologia_81992_102.html
    Previous1..3456789..18Next
Press   About   Terms of Use   Privacy   Free Weekly Reports   

© The Herd Locker 2016-2020. Bugs, questions or suggestions? Want to track a new hashtag? Just ask.

Loading…